Cargando…
Two cases of atypical femoral fracture in cancer patients administered with bone-modifying agents
Objective: We report two cases of atypical femoral fracture (AFF) in patients with cancer. Patients: Two patients, a 53-year-old woman with breast cancer and a 77-year-old man with prostate cancer, could not walk after being injured in a fall. They used bone-modifying agents (BMA) for the prevention...
Autores principales: | Fuchioka, Yusuke, Suzuki, Kohji, Kimura, Hiroaki, Furuoka, Hideto, Tamura, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Association of Rural Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249369/ https://www.ncbi.nlm.nih.gov/pubmed/34239630 http://dx.doi.org/10.2185/jrm.2020-061 |
Ejemplares similares
-
Multicenter study on atypical femoral fractures in patients with bone metastases taking bone- modifying agents
por: Fukui, Tomoaki, et al.
Publicado: (2023) -
Prevalence of Precursory Signs of Atypical Femoral Fractures in Patients Receiving Bone‐Modifying Agents for Bone Metastases: A Cross‐Sectional Study
por: Kaku, Takumi, et al.
Publicado: (2023) -
AN ‘ATYPICAL’ ATYPICAL FEMORAL FRACTURE
por: Arneill, Richard, et al.
Publicado: (2019) -
A Periprosthetic Femoral Fracture with Characteristics of Atypical Femoral Fracture
por: Tanaka, Shuya, et al.
Publicado: (2019) -
Denosumab and atypical femoral fractures
por: Aspenberg, Per
Publicado: (2014)